In a study, women undergoing a transobturator sling procedure had a 2.4-fold higher risk of reoperation for recurrent stress urinary incontinence than those undergoing a retropubic sling procedure.
The FDA has approved ProVate (ConTIPI) for the temporary, nonsurgical management of pelvic organ prolapse in women.
An over-the-counter device to treat stress urinary incontinence (SUI) in women has been made available by Rinovum Women’s Health.
The agency alleges manufacturers failed to provide evidence of the long-term safety of surgical mesh for transvaginal repair of anterior compartment prolapse.
Behavioral therapies relieve stress, urgency, and mixed urinary incontinence (UI) more effectively than drug monotherapies in nonpregnant women. In a new systematic review and network meta-analysis (NMA) of 84 randomized trials published in the Annals of Internal Medicine, most interventions including combination therapies improved or resolved women’s symptoms better than no treatment, whether sham or…
Findings from a small study suggest it could be an effective, safe, and attractive alternative to fluoroquinolones, bacterial resistance to which is becoming increasingly prevalent.
Lawsuits claim Johnson Johnson did not fully disclose safety risks of transvaginal mesh products.
Women younger than 46 years undergoing surgical correction are especially at risk for depression.
Poll finds that few women report talking to their physician about urinary leakage.
3 percent of midurethral mesh slings for stress urinary incontinence removed by 9 years